- Start: 02/09/2013
- End: 01/09/2016
FABIMED develops new replication-based manufacturing routes for medical microdevices. Production costs are meant to be reduced for diagnostic and therapy devices which require high degree of customization, and need to integrate advanced functionalities through micro/nano-scale features.
Three demonstrating devices have been defined to validate the manufacturing technologies
(i) : low cost microfluidic chip for PoCD
(ii) : plastic microneedle patch for programmable drug dispensing.
(iii) : Miniaturized ultrasound transducers for vascular surgery and neurosurgery.
AIMEN is the coordinator of a 12 partner consortium, which includes research institutions, medical sector SMEs, hi-tech companies and the Galician public health provider SERGAS.
Laser based micromachining is the main research activity of AIMEN within the project, particularly high precision toolmaking to produce functional parts directly by replication, through casting, injection and embossing processes.
**This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 608901.
- Sectors: Medical device
- Financing programme: 7TH FRAMEWORK PROGRAMME FUNDED EUROPEAN RESEARCH AND TECHNOLOGICAL DEVELOPMENT
- R&D&i: 3D Micropart production, Laser assisted processing, Microfabrication, Production of functional surfaces
- Partners: FRAUNHOFER-IWU Institute for Machine Tools and Forming Technology, APPLIED FUNCTIONAL MATERIALS LTD, ADAMA INNOVATIONS LTD, SENSLAB, University of Aveiro, INEGI, PROMOLDING BV, CROSPON LIMITED, TWOPTICS SYSTEMS DESIGN, S.L, SERGAS
- Acronym: FaBiMed
- Ambit: International
- Web: http://fabimed.aimen.es
FEDER